
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
PAR-3 CRISPR/Cas9 KO Plasmid (m) | sc-420266 | 20 µg | $397.00 |
Mouse F2rl2 encodes protease-activated receptor-3 (PAR-3), a member of the GPCR family activated in the context of extracellular protease signaling and coagulation-associated cues. PAR-3 participates in protease-activated receptor networks that can engage heterotrimeric G-protein signaling and coordinate downstream pathways influencing calcium flux, MAPK responses, and cytoskeletal remodeling in responsive cell types. In murine systems, F2rl2 is studied for its roles in vascular and inflammatory biology, platelet-associated signaling, and stromal-immune communication within tissue microenvironments. Dysregulated protease receptor signaling is relevant to models of thrombosis, inflammation, and cancer biology, where altered receptor expression or signaling tone can reshape cell migration and barrier-associated processes.
PAR-3 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the F2rl2 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the F2rl2 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the F2rl2 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish PAR-3 protein expression.
This CRISPR knockout system enables efficient generation of F2rl2-deficient cell models for investigation of PAR-3 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.